Healius Ltd.Healius Ltd.Healius Ltd.

Healius Ltd.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪709.94 M‬EUR
−0.6745EUR
‪−401.91 M‬EUR
‪1.09 B‬EUR
‪569.33 M‬
Beta (1Y)
1.32

About HEALIUS LIMITED


CEO
Paul Anderson
Headquarters
Sydney
Founded
1994
ISIN
AU0000033359
FIGI
BBG000HKWXM4
Healius Ltd. engages in the provision of healthcare technology solutions. It operates through the following segments: Pathology, Imaging, and Other. The Pathology segment provides pathology services. The Imaging segment focuses on imaging services from stand-alone imaging sites, hospitals, and medical centers. The Other segment consists of corporate functions. The company was founded by Edmund Gregory Thomas Bateman in 1985 and is headquartered in St. Leonards, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Healius Ltd. stocks are traded under the ticker PGZ.
We've gathered analysts' opinions on Healius Ltd. future price: according to them, PGZ price has a max estimate of 1.26 EUR and a min estimate of 0.80 EUR. Watch PGZ chart and read a more detailed Healius Ltd. stock forecast: see what analysts think of Healius Ltd. and suggest that you do with its stocks.
PGZ reached its all-time high on Apr 24, 2013 with the price of 3.7704 EUR, and its all-time low was 0.6450 EUR and was reached on May 2, 2024. View more price dynamics on PGZ chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Healius Ltd. financials in yearly and quarterly reports right on TradingView.
Healius Ltd. is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
PGZ earnings for the last half-year are 0.01 EUR per share, whereas the estimation was 0.01 EUR, resulting in a 14.16% surprise. The estimated earnings for the next half-year are 0.00 EUR per share. See more details about Healius Ltd. earnings.
Healius Ltd. revenue for the last half-year amounts to ‪558.61 M‬ EUR, despite the estimated figure of ‪548.33 M‬ EUR. In the next half-year revenue is expected to reach ‪556.84 M‬ EUR.
PGZ net income for the last half-year is ‪−6.22 M‬ EUR, while the previous report showed ‪−392.16 M‬ EUR of net income which accounts for 98.41% change. Track more Healius Ltd. financial stats to get the full picture.
As of Nov 13, 2024, the company has ‪10.50 K‬ employees. See our rating of the largest employees — is Healius Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Healius Ltd. EBITDA is ‪215.77 M‬ EUR, and current EBITDA margin is 19.85%. See more stats in Healius Ltd. financial statements.
Like other stocks, PGZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Healius Ltd. stock right from TradingView charts — choose your broker and connect to your account.